Despite advances in chemotherapy, the drugs used in cancer treatment remain rather
harmful to the cardiovascular system, causing structural and functional cardiotoxic changes …

Purpose To investigate the effects of dose reduction on image quality and lesion
detectability of oncological 18 F-FDG total-body PET/CT in pediatric oncological patients …

Chimeric antigen receptor (CAR) T cells effectively eradicate medullary B-cell acute
lymphoblastic leukemia (B-ALL) and can traffic to and clear central nervous system (CNS) …

Pediatric lymphoma is the third most common childhood cancer, representing 15% of all
pediatric malignancies. Evaluation of the extent of disease with imaging is essential for …

Malignant primary bone tumors are uncommon in the pediatric population, accounting for
3%–5% of all pediatric malignancies. Osteosarcoma and Ewing sarcoma comprise 90% of …

The use of PET/CT in adult oncology has been consolidated by several and authoritative
multicentric studies, metanalyses and systematic reviews. International guidelines help …

In children, adolescents, and young adults (CAYA), non-Hodgkin lymphoma (NHL) is
characterized by various age-related dissimilarities in tumor aggressiveness, prevailing …

Pediatric cancer, although rare, requires the most optimized treatment approach to obtain
high survival rates and minimize serious long-term side effects in early adulthood. 18F-FDG …

Simple Summary Positron emission tomography (PET)/computed tomography (CT) scans
are widely used as a form of full body imaging and allow for the early detection of small …

Rhabdomyosarcoma is the most common soft-tissue sarcoma of childhood. Despite clinical
advances, subsets of these patients continue to suffer high morbidity and mortality rates …